# Acute Lymphoblastic Leukemia Registry at Asan Medical Center

> **NCT01761682** · — · TERMINATED · sponsor: **Asan Medical Center** · enrollment: 200 (actual)

## Conditions studied

- Leukemia, Acute Lymphoblastic
- Precursor B-Cell Lymphoblastic Leukemia
- Leukemia, Biphenotypic, Acute
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
- Lymphoblastic Lymphoma

## Interventions

- **OTHER:** Diagnosed as ALL

## Key facts

- **NCT ID:** NCT01761682
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 200 (ACTUAL)
- **Why stopped:** The PI resigned the institute, and the rest investigators at the institute decided to terminate the study.
- **Last updated:** 2018-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761682, "Acute Lymphoblastic Leukemia Registry at Asan Medical Center". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01761682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*